ReCognition Health

London W1G9JF

4 studies enrolling now · 11 studies all time

What they study most

Alzheimer Disease, Alzheimer's Disease, Alzheimer's Disease, Early Onset, Alzheimers Disease, Autism Spectrum Disorder (ASD), Dementia With Lewy Bodies, Depression, Depression - Major Depressive Disorder, Depression Disorder, Depression Disorders, Depression in Adults, Major Depressive Disorder (MDD)

Studies at this site

• A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease — Recruiting now
• A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease — Recruiting now
• A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder — Recruiting now
• Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia — Recruiting now
• RewinD-LB - Clinical Study of Neflamapimod in Patients With Dementia With Lewy Bodies — Completed
• A Long-term Extension Study to Evaluate Safety, Tolerability, and Efficacy of AL002 in Alzheimer's Disease — Stopped early
• Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD) — Stopped early
• Efficacy and Safety of Bumetanide Oral Liquid Formulation in Children Aged From 2 to Less Than 7 Years Old With Autism Spectrum Disorder. — Stopped early
• Clinical Effect of Ampreloxetine (TD-9855) for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure — Completed
• A Study to Evaluate the Efficacy and Safety of Semorinemab in Patients With Prodromal to Mild Alzheimer's Disease — Stopped early
• A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD) — Stopped early